182 related articles for article (PubMed ID: 29880348)
1. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
Lee H; Lee S; Jeon JS; Kwon SH; Noh H; Han DC; Yun S; Song D
Transplant Proc; 2018 Jun; 50(5):1285-1288. PubMed ID: 29880348
[TBL] [Abstract][Full Text] [Related]
2. The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function.
Knight RJ; Kerman RH; Schoenberg L; Podder H; Van Buren CT; Katz S; Kahan BD
Transplantation; 2004 Sep; 78(6):904-10. PubMed ID: 15385812
[TBL] [Abstract][Full Text] [Related]
3. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
4. Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
Trofe J; Stratta RJ; Egidi MF; Lo A; Gaber LW; Shokouh-Amiri MH; Grewal HP; Honaker M; Hardinger K; Alloway RR; Gaber AO
Clin Transplant; 2002; 16 Suppl 7():34-44. PubMed ID: 12372042
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of single-dose anti-thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study.
Custodio LFP; Martins SBS; Viana LA; Cristelli MP; Requião-Moura L; Chow CYZ; Camargo SFDN; Nakamura MR; Foresto RD; Tedesco-Silva H; Medina-Pestana J
Pediatr Transplant; 2024 May; 28(3):e14713. PubMed ID: 38553819
[TBL] [Abstract][Full Text] [Related]
6. Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.
Folkmane I; Bicans J; Amerika D; Chapenko S; Murovska M; Rosentals R
Transplant Proc; 2001; 33(7-8):3209-10. PubMed ID: 11750377
[No Abstract] [Full Text] [Related]
7. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.
Lebranchu Y; Bridoux F; Büchler M; Le Meur Y; Etienne I; Toupance O; Hurault de Ligny B; Touchard G; Moulin B; Le Pogamp P; Reigneau O; Guignard M; Rifle G
Am J Transplant; 2002 Jan; 2(1):48-56. PubMed ID: 12095056
[TBL] [Abstract][Full Text] [Related]
8. Effects of Antithymocyte Globulin, Basiliximab, and Induction-Free Treatment in Living Donor Kidney Transplant Recipients on Tacrolimus-Based Immunosuppression.
Sonmez O; Ozcan SG; Karaca C; Atli Z; Dincer MT; Trabulus S; Seyahi N
Exp Clin Transplant; 2024 Apr; 22(4):270-276. PubMed ID: 38742317
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
[TBL] [Abstract][Full Text] [Related]
10. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
[TBL] [Abstract][Full Text] [Related]
11. Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol.
Rahamimov R; Yussim A; After T; Lustig S; Bar-Nathan N; Shaharabani E; Shapira Z; Shabthai E; Mor E
Transplant Proc; 2003 Mar; 35(2):653-4. PubMed ID: 12644082
[No Abstract] [Full Text] [Related]
12. Basiliximab: a review of its use as induction therapy in renal transplantation.
Chapman TM; Keating GM
Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
[TBL] [Abstract][Full Text] [Related]
13. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids.
Mourad G; Rostaing L; Legendre C; Garrigue V; Thervet E; Durand D
Transplantation; 2004 Aug; 78(4):584-90. PubMed ID: 15446319
[TBL] [Abstract][Full Text] [Related]
14. A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients.
Mariat C; Afiani A; Alamartine E; Thibaudin D; de Filippis JP; Berthoux F
Transplant Proc; 2001; 33(7-8):3192-3. PubMed ID: 11750368
[No Abstract] [Full Text] [Related]
15. A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.
Ponticelli C; Yussim A; Cambi V; Legendre C; Rizzo G; Salvadori M; Kahn D; Kashi H; Salmela K; Fricke L; Heemann U; Garcia-Martinez J; Lechler R; Prestele H; Girault D;
Transplantation; 2001 Oct; 72(7):1261-7. PubMed ID: 11602853
[TBL] [Abstract][Full Text] [Related]
16. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
Kahan BD; Rajagopalan PR; Hall M
Transplantation; 1999 Jan; 67(2):276-84. PubMed ID: 10075594
[TBL] [Abstract][Full Text] [Related]
17. BK polyomavirus DNAemia, allograft rejection, and de novo donor-specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients.
Huang HX; Xiang Y; George R; Winterberg P; Serluco A; Liverman R; Yildirim I; Garro R
Pediatr Transplant; 2024 Aug; 28(5):e14791. PubMed ID: 38808701
[TBL] [Abstract][Full Text] [Related]
18. Use of basiliximab with mycophenolate mofetil in kidney transplantation.
Baron PW; Weissman J; Ojogho ON; Sahney S; Cutler D; James S; Oculam C; Abdelhalim F; Nehlsen-Cannarella SL; Teichman S; Concepcion W
Transplant Proc; 2003 Dec; 35(8):2881-4. PubMed ID: 14697927
[TBL] [Abstract][Full Text] [Related]
19. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.
Vincenti F; Monaco A; Grinyo J; Kinkhabwala M; Roza A
Am J Transplant; 2003 Mar; 3(3):306-11. PubMed ID: 12614286
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Singer GG
Transplantation; 1999 Apr; 67(7):1011-8. PubMed ID: 10221486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
